Evidence map›Paper›PMID 25960704›Full record

ArticleJournal of medical and biological engineering

Enhanced Therapeutic Epidermal Growth Factor Receptor (EGFR) Antibody Delivery via Pulsed Ultrasound with Targeting Microbubbles for Glioma Treatment.

Ai-Ho Liao, Hsin-Yi Chou, Yi-Lei Hsieh, Sheng-Chieh Hsu, Kuo-Chen Wei, Hao-Li Liu

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical and biological engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Focused ultrasound for brain metastases.Neuro-oncology advances · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Nanobubble Contrast Enhanced Ultrasound Imaging: A Review.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ai-Ho LiaoGraduate Institute of Biomedical Engineering, National Taiwan University of Science and Technology, Taipei, 106 Taiwan.
Hsin-Yi ChouDepartment of Electrical Engineering, Chang Gung University, Taoyuan, 333 Taiwan.
Yi-Lei HsiehGraduate Institute of Biomedical Engineering, National Taiwan University of Science and Technology, Taipei, 106 Taiwan.
Sheng-Chieh HsuDepartment of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, 333 Taiwan.
Kuo-Chen WeiDepartment of Neurosurgery, Chang Gung University and Memorial Hospital, Linkou, Taoyuan, 333 Taiwan.
Hao-Li LiuDepartment of Electrical Engineering, Chang Gung University, Taoyuan, 333 Taiwan ; Medical Imaging Research Center, Institute for Radiological Research and Health Aging Research Center, Chang Gung University, Taoyuan, 333 Taiwan.
Chang Gung University · TWNational Taiwan University of Science and Technology · TWLinkou Chang Gung Memorial Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulsed-mode ultrasound (pUS) in combination with intravenously (IV) administered microbubbles (MBs) can enhance local drug delivery by temporarily enhancing capillary permeability. This study evaluates the use of epidermal growth factor receptor (EGFR)-targeting MBs after pUS treatment to enhance the effects of therapeutic-EGFR antibody delivery to glioma tumor cells in mice. Three animal groups were compared: (1) IV-injected non-targeting MBs, (2) IV-injected targeting MBs, and (3) IV-injected targeting MBs combined with pUS treatment. All animals were analyzed using high-frequency small-animal US imaging. The mean halftime of circulating targeting MBs was significantly increased from 3.13 min of targeting bubble alone to 5.86 min by targeting MBs combined with pUS treatment, compared to 2.34 min for non-targeting MBs. Compared to targeting bubble administration alone, pUS exposure prior to injection of targeting MBs was also significantly better at suppressing tumor growth when monitored for up to 35 days (

Indexed as

Epidermal growth factor receptorMicrobubblesPulsed ultrasound

Identifiers

PMID25960704
PMCPMC4414932
OpenAlexW272995187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.